There is no website visitor data available for this stock.
---
CAPS FAQ
What was Capstone Therapeutics Corp’s price range in the past 12 months?
Capstone Therapeutics Corp lowest stock price was $4.90 and its highest was $37.00 in the past 12 months.
What is Capstone Therapeutics Corp’s market cap?
Currently, no data Available
When is Capstone Therapeutics Corp’s upcoming earnings report date?
Capstone Therapeutics Corp’s upcoming earnings report date is Aug 15, 2023 which is 248 days ago.
How were Capstone Therapeutics Corp’s earnings last quarter?
Capstone Therapeutics Corp released its earnings results on May 12, 2023. The company reported -$12.512 earnings per share for the quarter, missing the consensus estimate of N/A by -$12.512.
Capstone Therapeutics Corp does not currently pay dividends.
What is Capstone Therapeutics Corp’s EPS estimate?
Capstone Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Capstone Therapeutics Corp have?
Capstone Therapeutics Corp has 54,385 shares outstanding.
What happened to Capstone Therapeutics Corp’s price movement after its last earnings report?
Capstone Therapeutics Corp reported an EPS of -$12.512 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Capstone Therapeutics Corp?
Currently, no hedge funds are holding shares in CAPS
Capstone Therapeutics Corp. is a biotechnology company. It develops a pipeline of novel therapeutic peptides and other molecules aimed at helping patients with under-served medical conditions. The company was founded in July 1987 and is headquartered in Tempe, AZ.